Influenza Vaccines Clinical Trial
Official title:
"Myths and Facts" About the Flu: Health Education Campaigns Can Reduce Vaccination Intentions
Objectives: To determine whether people systematically misremember the “myths” (false information) as true, and to assess effects on perceptions of risk and behavioral intentions.
Public information campaigns often warn people about false and unreliable medical claims by
juxtaposing “myths” and “facts.” The effectiveness of such communications has rarely been
assessed. We assessed whether people systematically misremember the “myths” (false
information) as true, and to assess effects on perceptions of risk and behavioral
intentions.
In an experimental study, participants read either a published CDC flyer on “Facts and
Myths” about the flu vaccine, or a “Facts Only” version; a separate control group read no
flyer. Participants completed the outcome measures either immediately or after 30 minutes.
Primary measures were memory for information about the flu presented in the flyer, ratings
of perceived risks associated with the flu, and personal intentions to get vaccinated in the
upcoming season.
After a delay of 30 minutes, participants who read the “Facts and Myths” flyer
systematically misremembered myths as facts. Both versions of the flyer had the immediate
effect of increasing intentions to get a flu vaccine, compared to the control group. After
30 minutes, however, participants who read the “Facts and Myths” flyer reported lower
intentions to get vaccinated, compared to those who read the same flyer with no delay, and
compared to all participants who read the “Facts Only” flyer.
In sum, people show a bias to think that incompletely remembered information is true,
turning “myths” into “facts.” Hence public information campaigns should emphasize
information that is true. Repeating false information, even as a warning, can create the
unintended consequence of belief in the information.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double-Blind, Primary Purpose: Educational/Counseling/Training
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03246100 -
Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates_2nd Trial in Colorado
|
N/A | |
Terminated |
NCT01195779 -
Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children
|
Phase 2 | |
Completed |
NCT02761551 -
Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates
|
N/A | |
Recruiting |
NCT05298800 -
Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23
|
Phase 4 | |
Completed |
NCT03735147 -
Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children
|
Phase 4 | |
Completed |
NCT02831608 -
Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis
|
Phase 4 | |
Completed |
NCT02560909 -
Adjuvanted Influenza Vaccine in Stem Cell Transplant
|
Phase 4 | |
Withdrawn |
NCT01623232 -
MAS-1 Adjuvanted Compared to Unadjuvanted Influenza Vaccines in the Elderly
|
Phase 1/Phase 2 | |
Completed |
NCT00961337 -
Evaluation of a School-based Influenza Vaccination Program
|
Phase 4 | |
Completed |
NCT00402805 -
Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy
|
Phase 4 | |
Completed |
NCT00222638 -
Influenza Vaccination and Oral Anticoagulant Therapy
|
Phase 4 | |
Active, not recruiting |
NCT03734237 -
A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD
|
Phase 4 | |
Completed |
NCT01013675 -
Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly
|
Phase 2 | |
Completed |
NCT00306995 -
Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population
|
Phase 2 | |
Completed |
NCT01310413 -
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
|
Phase 3 | |
Completed |
NCT00449670 -
Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults
|
Phase 3 | |
Completed |
NCT01788228 -
Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure
|
Phase 3 | |
Recruiting |
NCT05521763 -
Influenza Vaccine Uptake Among Healthcare Workers
|
N/A | |
Completed |
NCT00718120 -
Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years
|
Phase 3 | |
Completed |
NCT00430521 -
Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A)
|
Phase 2 |